Stock Taper
SCREENER COMPARE ANY 2 STOCKS
DRUG
BRIGHT MINDS BIOSCIENCES INC.
NASDAQ
$72.81
▼ DOWN 2.31% (-1.73)

KEY STATISTICS

Market Cap$712.60 M
52w High$123.75
52w Low$38.00
Dividend Yield—
Frequency—
P/E-35.00
Volume107.33K
Shares Out.9.79M

COMPANY

LEADERSHIP

Ian McDonald
CHIEF EXECUTIVE
Ian McDonald

ABOUT

SECTOR
Healthcare
WENT PUBLIC
March 22, 2021
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
26

PRICE TARGET

Target High$220.00
Target Low$145.00
Target Median$182.50
Target Consensus$182.50

UPCOMING EARNINGS

DateDec 22, 2026
DayTuesday
Rev. Est.—
DEC
22
TUE

SPLIT RECORD

DATETYPERATIO
2023-07-14Reverse1:5

PRICE

$72.81 ▼ DOWN 2.31% (−$1.73)
OVERLAYS
$72.75$73.50$74.259:32 AM10:37 AM11:41 AM12:45 PM1:50 PM2:55 PM3:59 PM72.81

About Bright Minds Biosciences Inc.

https://www.brightmindsbio.com ↗

Bright Minds Biosciences Inc. is a Vancouver-based pre-clinical company developing selective 5-HT receptor agonists for epilepsy, pain, and neuropsychiatry, with collaborations including NIH and universities.

INDUSTRY

Biotechnology

A PRODUCT BRIGHT MINDS BIOSCIENCES INC. IS KNOWN FOR

BMB-101
BMB-101

BMB-101 is a next-generation serotonin agonist with proven anti-seizure benefits in Phase 2 trials, advancing toward global registration and exploring treatments for neurological and psychiatric disorders, including Prader-Willi Syndrome.

COMPETITORS

COMPETITOR
HRMY COMPARE
OVID COMPARE
PRAX COMPARE
STOK COMPARE
XENE COMPARE

ETFS HOLDING THIS STOCK

ETFS HOLDING
12
LISTED HERE
6
RANKED BY POSITION SIZE
XSU.TO
0.02% · 191.9K
VTWO
0.02% · 41.6K
PSIL
4.11% · 31.8K
GWX
0.06% · 7.6K
RSSL
0.02% · 3.5K
URTY
0.01% · 300

INSTITUTIONAL OWNERSHIP

SHARES OWNED
71.65%
HOLDERS
105
TOP 12 OF 105 · RANKED BY POSITION SIZE
Janus Henderson Group Plc
1.3M sh · $93.52M
Cormorant Asset Management, LP
1.1M sh · $77.3M
Blackrock, Inc.
621.9K sh · $45.38M
Vivo Capital, LLC
557.2K sh · $40.66M
Braidwell LP
539.7K sh · $39.38M
Commodore Capital LP
500.0K sh · $30.33M
Adage Capital Partners Gp, L.L.C.
495.7K sh · $36.17M
Vestal Point Capital, LP
492.3K sh · $35.92M
Perceptive Advisors LLC
449.3K sh · $35.06M
Driehaus Capital Management LLC
432.5K sh · $31.56M
Balyasny Asset Management L.P.
297.2K sh · $21.68M
Deerfield Management Company, L.P. (Series C)
283.0K sh · $20.65M

RATINGS SNAPSHOT

Overall rating: C+

DCFROEROAD/EP/EP/B
Discounted Cash Flow3
Return On Equity1
Return On Assets1
Debt To Equity5
Price To Earnings1
Price To Book2
Overall Score2

INSIDER TRADES

★
OTHER: FORMER 10% OWNER
Cormorant Asset Management, LP
Sale · 109.3K shares
2026-04-28

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 3
OVERWEIGHT 1
4 GRADES IN THE LAST 12 MONTHS
HC Wainwright & Co. BUY BTIG BUY Piper Sandler OVERWEIGHT Chardan Capital BUY

SECTORS PEERS

PEERPRICE
LBRX$47.73COMPARE
DSGN$15.11COMPARE
ANNX$4.97COMPARE
AURA$7.40COMPARE
ALT$3.11COMPARE
DMAC$6.39COMPARE
GALT$4.02COMPARE
KRRO$12.91COMPARE